Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Rethinking HEOR Market Access Integration: A Ca...
By
João L. Carapinha
November 24, 2025
Early HEOR Market Access Integration In this brief interview on ISPOR, Indranil Bagchi asserts that HEOR market access integration must o...
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Systems Thinking in Pharmaceutical Access: Future-Proofing Value Strategy
Catalyzing Value-Based Care Through Patient-Centered Outcomes
A Value Framework for Next-Generation Sequencing in Europe: Access to Precisi...
Expanding the Value Metrics in Fixed-Budget Healthcare Systems
Best Practices for Preventing Statistical Pitfalls in Observational Research
Innovative Funding Models for Non-Communicable Diseases
Innovative Technology Policy: Simulation Modelling in Healthcare
Digital Health: The Impact of Standardising DHI Terminology
Willingness to Pay for Innovative Oncology Treatments
Health Economics and Outcomes Research in Global Healthcare
The Patient-Centric Approach in Health Economics
1
2
Next »